Replies to post #116488 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

With current shares outstanding, not including warrants, that's about $5B market cap at approximately $30.00 per share.

Still cheap for them. What if it were much more highly valued now and still on NASDAQ? Juno has been that much without a product.

However, I suspect anyone watching professionally, at this point, will have accumulated some, but remain incredibly greedy in their efforts to wait until the last minute, and get the lowest price, with the most certainty.

And as we've seen with other companies, they rarely pop that high in the first few hours, so anyone following closely, and a hedge fund trader is going to have all manner of alerts and know as soon as any news comes out, they are likely going to cover or have what they need long before it hits $30 or anywhere near that number.

Remember, it's not that long ago that it was over $13.

[Etienne1]

Always nice to see you around, 'The Follower', an old timer like me! I just added 15k shares and I've got another 50k ready. I wont sell cheap either. NWBO'S platform with Dcvax-L and Direct is broad and applicable for a wide range of operable and inoperable cancers. They have the patents and I trust mgm all the way. They put their own money in it. So do I.